Phase 3 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able to understand the study and are willing to sign a written consent form agreeing to take part.
- People aged between 18 and 75 years, of any sex.
- People who have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC), confirmed through laboratory testing of tissue samples, of either the squamous or non-squamous type.
- People who are able to provide suitable tumour tissue samples for testing.
- People whose lung cancer does not have specific gene changes (called actionable genomic alterations) that would point to a different treatment, as confirmed by laboratory testing.
- People whose cancer did not show a major response to pre-surgery treatment, as assessed by a central independent review committee.
- People with stage II to IIIB NSCLC (using international lung cancer staging guidelines) who have had a complete surgical removal of the cancer, with laboratory testing confirming that all edges of the removed tissue are free of cancer cells (known as R0 resection).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who, in the treating doctor's opinion, need further surgery.
- People diagnosed with stage IIIB lung cancer involving certain lymph nodes (N3), or with stage IIIC, IVA, or IVB lung cancer.
- People for whom only an incomplete surgical removal of the tumour is possible.
- People with more than one primary lung cancer occurring at the same time, multiple primary cancers in different parts of the body, or a mixed type of lung cancer involving both small cell and non-small cell types.
- People who have had an allergic reaction to, or a medical reason to avoid, any ingredient in the study treatment.
- People who have received or are planned to receive radiation therapy before or after surgery for this cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 031169085587
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Disease-Free Survival (DFS) assessed by the independent review committee (IRC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.